文献速递肝胆胰外科围术期管理与 ERAS

胰腺切除术后并发症与抢救失败及医院参与美国外科医师学会国家外科质量改进计划靶向登记的关系

Complications and failure-to-rescue after pancreatectomy and hospital participation in the targeted American College of Surgeons National Surgical Quality Improvement Program registry.
PubMed 文献 · Surgery · 2023-08-22

该研究基于2014至2019年美国外科医师学会国家外科质量改进计划(ACS NSQIP)胰腺靶向与标准登记数据,比较参与靶向登记的医院与标准医院在胰腺切除术后的结局。多变量分析显示,靶向医院行胰十二指肠切除术与30天死亡率降低39%、严重并发症降低17%、抢救失败降低41%相关,但远端胰腺切除术无此差异;靶向登记参与与两种手术的最佳手术率较高相关。

要点

  • 靶向医院行胰十二指肠切除术的30天死亡率、严重并发症和抢救失败均低于标准医院。
  • 靶向医院与标准医院在远端胰腺切除术的上述结局上无差异。
  • 靶向登记参与与胰十二指肠切除术和远端胰腺切除术的最佳手术率较高相关。

核心结论

  • 靶向医院行胰十二指肠切除术后的死亡率和抢救失败率接近标准ACS NSQIP医院的一半。

研究设计与样本

  • 回顾性分析2014至2019年ACS NSQIP胰腺靶向与标准登记数据,纳入30,357例胰十二指肠切除术(80%在靶向医院)和14,800例远端胰腺切除术(76%在靶向医院),采用单变量和多变量logistic回归分析。

主要发现

  • 多变量分析显示,靶向医院行胰十二指肠切除术与30天死亡率降低39%相关(比值比0.61;95%置信区间0.50-0.75)。
  • 靶向医院行胰十二指肠切除术与严重并发症降低17%相关(比值比0.83;95%置信区间0.77-0.89)。
  • 靶向医院行胰十二指肠切除术与抢救失败降低41%相关(比值比0.59;95%置信区间0.47-0.74)。
  • 上述差异不适用于远端胰腺切除术。
  • 参与靶向登记与胰十二指肠切除术最佳手术率较高相关(比值比1.33;95%置信区间1.25-1.41),与远端胰腺切除术最佳手术率较高相关(比值比1.17;95%置信区间1.06-1.30)。

局限性

  • 需进一步研究以阐明该效应背后的因素并突出改进机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: More than 700 hospitals participate in the American College of Surgeons National Surgical Quality Improvement Program, but most pancreatectomies are performed in 165 centers participating in the pancreas procedure-targeted registry. We hypothesized that these hospitals ("targeted hospitals") might provide more specialized care than those not participating ("standard hospitals"). METHODS: The 2014 to 2019 pancreas-targeted and standard American College of Surgeons National Surgical Quality Improvement Program registry were reviewed regarding patient demographics, comorbidities, and perioperative outcomes using standard univariate and multivariable logistic regression analyses. Primary outcomes included 30-day mortality and serious morbidity. RESULTS: The registry included 30,357 pancreatoduodenectomies (80% in targeted hospitals) and 14,800 distal pancreatectomies (76% in targeted hospitals). Preoperative and intraoperative characteristics of patients treated at targeted versus standard hospitals were comparable. On multivariable analysis, pancreatoduodenectomies performed at targeted hospitals were associated with a 39% decrease in 30-day mortality (odds ratio, 0.61; 95% confidence interval, 0.50-0.75), 17% decrease in serious morbidity (odds ratio, 0.83; 95% confidence interval, 0.77-0.89), and 41% decrease in failure-to-rescue (odds ratio, 0.59; 95% confidence interval, 0.47-0.74). These differences did not apply to distal pancreatectomies. Participation in the targeted registry was associated with higher rates of optimal surgery for both pancreatoduodenectomy (odds ratio, 1.33; 95% confidence interval, 1.25-1.41) and distal pancreatectomy (odds ratio, 1.17; 95% confidence interval, 1.06-1.30). CONCLUSION: Mortality and failure-to-rescue rates after pancreatoduodenectomy in targeted hospitals were nearly half of rates in standard American College of Surgeons National Surgical Quality Improvement Program hospitals. Further research should delineate factors underlying this effect and highlight opportunities for improvement.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Vawter K, Kuhn S, Pitt H, et al. Complications and failure-to-rescue after pancreatectomy and hospital participation in the targeted American College of Surgeons National Surgical Quality Improvement Program registry. Surgery. 2023. PMID: 37612210. doi:10.1016/j.surg.2023.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。